Migraine is a common neurologic disorder associated with considerable pain and disruption of daily function among school children. Given the impact of migraine on academics and social engagement, ensuring robust support in the school setting is vital to the well-being and development of students affected by migraine. School nurses have an active role in providing and coordinating care, acting as the critical link between care providers, families, and educators to promote health among students with migraine. We aim to equip school nurses and educational staff with practical tools for helping students manage migraine pain in the school setting. We suggest a comprehensive approach, including the use of medications, psychological and complementary interventions, and school accommodation plans, with a focus on both prevention and management.
AhmedM.BoydC.VavilikolanuR.RafiqueB. (2018). Visual symptoms and childhood migraine: Qualitative analysis of duration, location, spread, mobility, colour and pattern. Cephalalgia, 38(14), 2017–2025. https://doi.org/10.1177/0333102418766872
2.
AnchetaA. J.BruzzeseJ.-M.HughesT. L. (2021). The impact of positive school climate on suicidality and mental health among LGBTQ adolescents: A systematic review. The Journal of School Nursing, 37(2), 75–86. https://doi.org/10.1177/1059840520970847
3.
AshinaS.SaitH.BendtsenL.BursteinR.IljaziA.JensenR. H.LiptonR. B. (2023). Pain sensitivity in relation to frequency of migraine and tension-type headache with or without coexistent neck pain: An exploratory secondary analysis of the population study. Scandinavian Journal of Pain, 23(1), 76–87. https://doi.org/10.1515/sjpain-2022-0030
4.
BakhshaieJ.PennT. M.DoorleyJ.PhamT. V.GreenbergJ.BannonS.SaadiA.VranceanuA. M. (2022). Psychosocial predictors of chronic musculoskeletal pain outcomes and their contextual determinants among Black individuals: A narrative review. The Journal of Pain, 23(10), 1697–1711. https://doi.org/10.1016/j.jpain.2022.04.013
5.
Begasse de DhaemO.KiarashiJ.ArmandC. E.CharlestonL.IVSzperkaC. L.LeeY. S.RajapakseT.SengE. K.VanderPluymJ. H.StarlingA. J. (2021). Eleven things to facilitate participation of underrepresented groups in headache medicine research. Headache: The Journal of Head and Face Pain, 61(6), 951–960. https://doi.org/10.1111/head.14124
BrennerM.LewisD. (2008). The treatment of migraine headaches in children and adolescents. The Journal of Pediatric Pharmacology and Therapeutics, 13(1), 17–24. https://doi.org/10.5863/1551-6776-13.1.17
8.
BrueckleM. S.ThomasE. T.SeideS. E.PilzM.Gonzalez-GonzalezA. I.NguyenT. S.HarderS.GlasziouP. P.GerlachF. M.MuthC. (2020). Adverse drug reactions associated with amitriptyline: Protocol for a systematic multiple-indication review and meta-analysis. Systematic Reviews, 9(1), 59. https://doi.org/10.1186/s13643-020-01296-8
9.
CallistoS. P.IllamolaS. M.BirnbaumA. K.BarkleyC. M.BathenaS. P. R.LeppikI. E.MarinoS. E. (2020). Severity of topiramate-related working memory impairment is modulated by plasma concentration and working memory capacity. Journal of Clinical Pharmacology, 60(9), 1166–1176. https://doi.org/10.1002/jcph.1611
10.
ChatterjeeJ. H.BlumeH. K. (2024). Triptans in the acute migraine management of children and adolescents: An update. Current Pain and Headache Reports, 28(5), 641–649. https://doi.org/10.1007/s11916-024-01213-x
11.
ChowdhuryD.BansalL.DuggalA.DattaD.KoulA.MundraA.KrishnanA.GuptaA. (2021). Topiramate versus propranolol for prevention of chronic migraine: A randomized double-blind controlled trial. Journal of the Neurological Sciences, 429, 117722. https://doi.org/10.1016/j.jns.2021.117722
12.
ChristianL. M.ColeS. W.McDadeT.PachankisJ. E.MorganE.StrahmA. M.Kamp DushC. M. (2021). A biopsychosocial framework for understanding sexual and gender minority health: A call for action. Neuroscience and Biobehavioral Reviews, 125, 244–254. https://doi.org/10.1016/j.neubiorev.2021.02.028
13.
ConnellyM.BickelJ.WingertT.GalemoreC. (2018). The headache action plan project for youth (HAPPY): School nurses as facilitators of system change in pediatric migraine care. NASN School Nurse, 33(1), 40–47. https://doi.org/10.1177/1942602x17719300
EspositoM.GallaiB.ParisiL.RoccellaM.MarottaR.LavanoS. M.GrittiA.MazzottaG.CarotenutoM. (2013). Maternal stress and childhood migraine: A new perspective on management. Neuropsychiatric Disease and Treatment, 9, 351–355. https://doi.org/10.2147/NDT.S42818
16.
FisherE.VillanuevaG.HenschkeN.NevittS. J.ZempskyW.ProbynK.BuckleyB.CooperT. E.SethnaN.EcclestonC. (2022). Efficacy and safety of pharmacological, physical, and psychological interventions for the management of chronic pain in children: A WHO systematic review and meta-analysis. Pain, 163(1), e1–e19.
17.
GarmyP.RahrC.PerssonL.EinbergE.-L. (2023). School nurses’ perspectives on health among school-aged children and adolescents during the COVID-19 pandemic. The Journal of School Nursing, 39(2), 150–155. https://doi.org/10.1177/10598405221126345
18.
GelfandA. A.IrwinS. L. (2020). Lifestyle advice for pediatric migraine: Blaming the patient, or evidence based?Seminars in Neurology, 40(3), 277–285. https://doi.org/10.1055/s-0040-1708868
19.
GelfandA. A.PavittS.RossA. C.SzperkaC. L.IrwinS. L.BertischS.StoneK. L.FrazierR.GrimesB.AllenI. E. (2021). Later high school start time is associated with lower migraine frequency in adolescents. Headache, 61(2), 343–350. https://doi.org/10.1111/head.14016
HaraldstadK.SteaT. H. (2021). Associations between pain, self-efficacy, sleep duration, and symptoms of depression in adolescents: A cross-sectional survey. BMC Public Health, 21, 1617. https://doi.org/10.1186/s12889-021-11680-1
JacksonJ. L.KuriyamaA.KuwatsukaY.NickoloffS.StorchD.JacksonW.ZhangZ. J.HayashinoY. (2019). Beta-blockers for the prevention of headache in adults: A systematic review and meta-analysis. PLoS One, 14(3), e0212785.
25.
JamesA. C.ReardonT.SolerA.JamesG.CreswellC. (2020). Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database of Systematic Reviews, 11(11), CD013162.
26.
KafleM.MireaL.GageS. (2022). Association of psychiatric comorbidities with treatment and outcomes in pediatric migraines. Hospital Pediatrics, 12(3), e101–e105. https://doi.org/10.1542/hpeds.2021-006085
KiarashiJ.Halker SinghR. B. (2024). Diversity, equity, and inclusion in headache care and research. Continuum: Lifelong Learning in Neurology, 30(2), 498–511. https://doi.org/10.1212/CON.0000000000001416
29.
KitschenA.WahidieD.MeyerD.RauL. M.RuheA. K.WagerJ.ZernikowB.SauerlandD. (2024). Cost-of-illness and economic evaluation of interventions in children and adolescents with chronic pain: A systematic review. The Clinical Journal of Pain, 40(5), 306–319. https://doi.org/10.1097/AJP.0000000000001199
30.
MitterV. R.LupattelliA.BjørkM.-H.NordengH. M. E. (2024). Identification and characterization of migraine in pregnancy: A Norwegian registry-based cohort study. Cephalalgia, 44(4), 3331024241248846. https://doi.org/10.1177/03331024241248846
31.
NagpalM.RadliffK. (2024). A systematic review of mindfulness-based school interventions on social emotional outcomes with adolescents. Child & Youth Care Forum, 53, 563–610. https://doi.org/10.1007/s10566-023-09783-4
National Association of School Nurses. (2023). NASN position statement: IDEIA and Section 504 teams—The school nurse as an essential team member. NASN School Nurse, 38(4), 215–216. https://doi.org/10.1177/1942602X231177119
34.
National Association of School Nurses. (2024). A contemporary Framework update for today’s school nursing landscape: Introducing the School Nursing Practice FrameworkTM. NASN School Nurse, 39(3), 140–147. https://doi.org/0.1177/1942602X241241092
NgQ. X.VenkatanarayananN.KumarL. (2017). A systematic review and meta-analysis of the efficacy of cognitive behavioral therapy for the management of pediatric migraine. Headache, 57(3), 349–362. https://doi.org/10.1111/head.13016
37.
OkumaH.IijimaK.YasudaT.TokuokaK.KitagawaY. (2013). Preventive effect of cyproheptadine hydrochloride in refractory patients with frequent migraine. SpringerPlus, 2(1), 573. https://doi.org/10.1186/2193-1801-2-573
38.
OnofriA.PensatoU.RosignoliC.Wells-GatnikW.StanyerE.OrnelloR.ChenH. Z.De SantisF.TorrenteA.MikulenkaP.MonteG.MarschollekK.Waliszewska-ProsółM.WielsW.BoucherieD. M.OnanD.FarhamF.Al-HassanyL.SaccoS. (2023). Primary headache epidemiology in children and adolescents: A systematic review and meta-analysis. The Journal of Headache and Pain, 24(1), 8. https://doi.org/10.1186/s10194-023-01541-0
39.
OrabyM. I.SolimanR. H.MahmoudM. A.ElfarE.ElMonemN. (2021). Migraine prevalence, clinical characteristics, and health care-seeking practice in a sample of medical students in Egypt. Egyptian Journal of Neurology Psychiatry and Neurosurgery, 57(26), 1–7. https://doi.org/10.1186/s41983-021-00282-8
40.
PaceA.BarberM.ZiplowJ.HranilovichJ. A.KaiserE. A. (2021). Gender minority stress, psychiatric comorbidities, and the experience of migraine in transgender and gender-diverse individuals: A narrative review. Current Pain and Headache Reports, 25(12), 82. https://doi.org/10.1007/s11916-021-00996-7
41.
PalermoT. M. (2012). Cognitive-behavioral therapy for chronic pain in children and adolescents (pp. 25–40). Oxford University Press.
42.
PapettiL.SpaliceA.NicitaF.PaolinoM. C.CastaldoR.IannettiP.VillaM. P.ParisiP. (2010). Migraine treatment in developmental age: Guidelines update. The Journal of Headache and Pain, 11(3), 267–276. https://doi.org/10.1007/s10194-010-0205-4
43.
ParuthiS.BrooksL. J.D’AmbrosioC.HallW. A.KotagalS.LloydR. M.MalowB. A.MaskiK.NicholsC.QuanS. F.RosenC. L.TroesterM. M.WiseM. S. (2016). Recommended amount of sleep for pediatric populations: A consensus statement of the American Academy of Sleep Medicine. Journal of Clinical Sleep Medicine, 12(6), 785–786. https://doi.org/10.5664/jcsm.5866
PearlN. Z.BabinC. P.CatalanoN. T.BlakeJ. C.AhmadzadehS.ShekoohiS.KayeA. D. (2023). Narrative review of topiramate: Clinical uses and pharmacological considerations. Advances in Therapy, 40(9), 3626–3638. https://doi.org/10.1007/s12325-023-02586-y
46.
RaucciU.BoniA.EvangelistiM.Della VecchiaN.VelardiM.UrsittiF.TerrinG.Di NardoG.RealeA.VillaniA.ParisiP. (2021). Lifestyle modifications to help prevent headache at a developmental age. Frontiers in Neurology, 11, 618375. https://doi.org/10.3389/fneur.2020.618375
47.
RicherL.BillinghurstL.LinsdellM. A.RussellK.VandermeerB.CrumleyE. T.DurecT.KlassenT. P.HartlingL. (2016). Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database of Systematic Reviews, 2020(10), 15–20. https://doi.org/10.1002/14651858.cd005220.pub2
48.
RodriguezV. E.EnriquezL. E.RoA.AyónC. (2023). Immigration-related discrimination and mental health among Latino undocumented students and U.S. citizen students with undocumented parents: A mixed-methods investigation. Journal of Health and Social Behavior, 64(4), 593–609. https://doi.org/10.1177/00221465231168912
49.
SchneiderM. B.FriedmanS. B.FisherM. (1995). Stated and unstated reasons for visiting a high school nurse’s office. Journal of Adolescent Health, 16(1), 35–40. https://doi.org/10.1016/1054-139x(95)94071-f
50.
ShapiroS. L.CarlsonL. E.AstinJ. A.FreedmanB. (2006). Mechanisms of mindfulness. Journal of Clinical Psychology, 62(3), 373–386. https://doi.org/10.1002/jclp.20237
51.
SolotareffL.CuvellierJ. C.DuhamelA.ValléeL.TichS. N. T. (2017). Trigger factors in childhood migraine: A prospective clinic-based study from north of France. Journal of Child Neurology, 32(8), 754–758. https://doi.org/10.1177/0883073817705251
TekinH.EdemP. (2022). Effects and side effects of migraine prophylaxis in children. Pediatrics International, 64(1), e15094. https://doi.org/10.1111/ped.15094
55.
TeleanuR. I.VladacencoO.TeleanuD. M.EpureD. A. (2016). Treatment of pediatric migraine: A review. Maedica, 11(2), 136–143.
56.
TurnerS. B.SzperkaC. L.HersheyA. D.LawE. F.PalermoT. M.GroenewaldC. B. (2021). Association of headache with school functioning among children and adolescents in the United States. JAMA Pediatrics, 175(5), 522. https://doi.org/10.1001/jamapediatrics.2020.5680
57.
UrsittiF.ValerianiM. (2023). Migraine in childhood: Gender differences. European journal of Paediatric Neurology, 42, 122–125. https://doi.org/10.1016/j.ejpn.2023.01.002
58.
WehbeA. T.CostaT. E.AbbasS. A.CostaJ. E.CostaG. E.WehbeT. W. (2022). The effects of the COVID-19 confinement on screen time, headaches, stress and sleep disorders among adolescents: A cross-sectional study. Chronic Stress (Thousand Oaks), 6, 24705470221099836. https://doi.org/10.1177/24705470221099836
59.
WhiteC. S. (2023). Unique considerations in episodic migraine: Underserved populations. Current Pain and Headache Reports, 27(10), 503–509. https://doi.org/10.1007/s11916-023-01152-z
60.
WinnerP.PearlmanE. M.LinderS. L.JordanD. M.FisherA. C.HulihanJ., & Topiramate Pediatric Migraine Study Investigators. (2005). Topiramate for migraine prevention in children: A randomized, double-blind, placebo-controlled trial. Headache, 45(10), 1304–1312. https://doi.org/10.1111/j.1526-4610.2005.00262.x
61.
WuX.ZhangY.LuM.YuX.YeX.WangX.ShanP. (2020). The efficacy and safety of topiramate in the prevention of pediatric migraine: An update meta-analysis. Frontiers in Pediatrics, 8, 28. https://doi.org/10.3389/fped.2020.00028
62.
YoussefP. E.MackK. J. (2020). Episodic and chronic migraine in children. Developmental Medicine and Child Neurology, 62(1), 34–41. https://doi.org/10.1111/dmcn.14338
